Splenic rupture in a patient with acute myeloid leukemia undergoing peripheral blood stem cell transplantation
β Scribed by C. Kasper; L. Jones; Y. Fujita; G. R. Morgenstern; J. H. Scarffe; J. Chang
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 42 KB
- Volume
- 78
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Splenic rupture (SR) is a rare adverse event observed in patients treated with GβCSF as a peripheral hematopoietic stem cell (PHSC) mobilizing agent, mostly in myeloma multiple and amiloidosis; to date, to our knowledge, it has not been previously described in plasmaβcell leukemia (PCL)
Although a second stem cell transplantation (SCT) can be used as salvage therapy in patients with relapsing leukemia after SCT, most of these patients have a poor outcome. We tried clinical vaccination using monocyte-derived dendritic cells (DCs) pulsed with leukemic lysates to treat relapsing acute